Baillie Gifford & Co
SMMT icon

Baillie Gifford & Co’s Summit Therapeutics SMMT Stock Holding History

Baillie Gifford & Co’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-436,512
Closed -$1.07M – 507
2022
Q1 		$1.07M Hold
436,512
– – ﹤0.01% 274
2021
Q4 		$1.17M Hold
436,512
– – ﹤0.01% 275
2021
Q3 		$2.19M Hold
436,512
– – ﹤0.01% 264
2021
Q2 		$3.26M Buy
436,512
+64,251
+17% +$421K ﹤0.01% 263
2021
Q1 		$2.19M Hold
372,261
– – ﹤0.01% 256
2020
Q4 		$1.75M Hold
372,261
– – ﹤0.01% 245
2020
Q3 		$1.28M Buy
+372,261
New +$1.29M ﹤0.01% 237

Other funds holding SMMT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AGM
Alpine Global Management New York $658M AUM 20.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return